GlassScriptPhysician profile
Kimngan Tran
NPI 1609181007
$635.90
in general payments reported to CMS, 2019-2025
11 companies · $156 in 2025
The $156 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $124 · 2021: $117 · 2022: $47.27 · 2023: $138 · 2024: $53.21 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $347.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $347.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $124.35 | 2020 | |
| Astellas Pharma US INC | $111.40 | 2023 | Veozah |
| Biogen, INC. | $111.21 | 2025 | Zurzuvae |
| Abbvie INC. | $70.25 | 2021-2022 | |
| Evofem Biosciences, INC. | $59.78 | 2021 | |
| Pfizer INC. | $53.73 | 2022-2024 | |
| Sage Therapeutics, LLC | $30.08 | 2025 | Zurzuvae |
| Dexcom, INC. | $26.40 | 2023 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $19.39 | 2024 | Vaxneuvance, Vaxelis, Vaqta |
| Supernus Pharmaceuticals, INC. | $14.78 | 2025 | Qelbree |
| Exact Sciences Corporation | $14.53 | 2024 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimngan Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.